BioSpace News Archive

Liminal BioSciences Inc. today announced that they have entered into a definitive arrangement agreement (the “Arrangement Agreement”) under which SALP will acquire all of the issued and outstanding common shares of Liminal BioSciences (the “Common Shares”) that it does not already own.

Medical device and technology company Lazurite today announced that James Voos, M.D. has joined the company’s medical advisory board.

Akoya Biosciences, Inc. today announced that it will release financial results for the second quarter of 2023 after the market close on Monday, August 7th , 2023.

Ocular Therapeutix, Inc. today announced the appointment of Adrienne L. Graves, Ph.D., to its Board of Directors.

Bridge to Life Ltd., a leading global supplier of organ preservation and perfusion technologies, announced results from interim analysis of its multicenter, randomized, controlled liver clinical trial presented at the 2023 American Transplant Congress.

Revvity (NYSE: RVTY), today announced that it will release its second quarter 2023 financial results prior to market open on Tuesday, August 1, 2023.

T2 Biosystems, Inc. today announced preliminary unaudited financial and operational results for the second quarter 2023.

bioAffinity Technologies, Inc. announced that the American Medical Association has released a Current Procedural Terminology code specifically for use with CyPath® Lung, a noninvasive test for early-stage lung cancer.

VICHY Laboratoires announced today a partnership with Embr Labs, a leading health-tech company addressing hot flashes and sleep to help women thrive in peri- and post-menopause.

Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company focused on early intervention orthopedics, today announced it will highlight core products from its joint preservation and restoration portfolio at the 2023 American Orthopaedic Society for Sports Medicine (AOSSM) Annual Meeting on July 13-16th in Washington, D.C.